Your browser doesn't support javascript.
loading
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab.
Cattaneo, C; Cancelli, V; Imberti, L; Dobbs, K; Sottini, A; Pagani, C; Belotti, A; Re, A; Anastasia, A; Quaresima, V; Tucci, A; Chiorini, J A; Su, H C; Cohen, J I; Burbelo, P D; Rossi, G; Notarangelo, L D.
Afiliação
  • Cattaneo C; Hematology, ASST Spedali Civili, Brescia, Italy. chiara.cattaneo@asst-spedalicivili.it.
  • Cancelli V; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Imberti L; CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Dobbs K; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Sottini A; CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Pagani C; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Belotti A; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Re A; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Anastasia A; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Quaresima V; CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Tucci A; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Chiorini JA; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA.
  • Su HC; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Cohen JI; Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD, USA.
  • Burbelo PD; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA.
  • Rossi G; Hematology, ASST Spedali Civili, Brescia, Italy.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Blood Cancer J ; 11(9): 151, 2021 09 14.
Article em En | MEDLINE | ID: mdl-34521813
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Imunidade Humoral / Rituximab / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Imunidade Humoral / Rituximab / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article